<PAGE> 1
As filed with the Securities and Exchange Commission on April 20, 2000
REGISTRATION NO. 333-95353
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------
POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
-----------------
ILEX ONCOLOGY, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 74-2699185
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
11550 I.H. 10 WEST, SUITE 100
SAN ANTONIO, TEXAS 78230
(210) 949-8200
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
-----------------
MICHAEL T. DWYER
SENIOR VICE PRESIDENT-ADMINISTRATION
ILEX ONCOLOGY, INC.
11550 I.H. 10 WEST, SUITE 100
SAN ANTONIO, TEXAS 78230
(210) 949-8200
(Name, address, including zip code and telephone number,
including area code, of agent for service)
---------------
Copy to:
PHILLIP M. RENFRO
FULBRIGHT & JAWORSKI L.L.P.
300 CONVENT STREET, SUITE 2200
SAN ANTONIO, TEXAS 78205
(210) 224-5575
-----------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: From
time to time after this Registration Statement becomes effective.
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [ ]
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with
dividend or interest reinvestment plans, check the following box. [X]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(c) under the Securities Act of 1933, please check the
following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act of 1933, check the following box and list the
Securities Act registration statement number of the earlier effective
registration for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule
434, please check the following box. [ ]
<PAGE> 2
Deregistration
This Post-Effective Amendment No. 1 is being filed to amend the
Registration Statement (the "Registration Statement") on Form S-3 (No.
333-95353), pursuant to which ILEX Oncology, Inc., a Delaware corporation (the
"Registrant"), registered the resale of 1,255,988 shares of its common stock,
$.01 par value ("Common Stock").
The Selling Stockholder has completed the resale of all of the shares
of Common Stock registered in the Registration Statement and such offering has
been terminated. Pursuant to the undertakings set forth in the Registration
Statement and pursuant to Rule 478 of the Securities Act of 1933, as amended,
Registrant hereby withdraws from registration the Registration Statement. The
Registration Statement is hereby amended, as appropriate, to reflect such
deregistration.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets
all the requirements for filing on Form S-3 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of San Antonio and State of Texas the 20th day of
April, 2000.
ILEX ONCOLOGY, INC.
By: /s/ GREGORY L. WEAVER
------------------------------
Gregory L. Weaver
Vice President and
Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each individual whose signature
appears below constitutes and appoints Michael T. Dwyer and Ronald G. Tefteller,
or either of them, his true and lawful attorney-in-fact and agent, with full
power of substitution and resubstitution, for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments (including
post-effective amendments) to this Registration Statement, and to file the same
and all exhibits thereto, and all documents in connection therewith, with the
Securities and Exchange Commission, granting said attorney-in-fact and agent,
and each of them, full power and authority to do and perform each and every act
and thing requisite and necessary to be done in and about the premises, as fully
to all intents and purposes as he might or could do in person, hereby ratifying
and confirming all that said attorney-in-fact and agent or either of them, or
their or his substitute or substitutes, may lawfully do or cause to be done by
virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
<TABLE>
<CAPTION>
<S> <C> <C>
SIGNATURE TITLE DATE
- --------- ----- ----
/s/ GARY V.WOODS * Chairman of the Board April 20, 2000
- ------------------------------------
Gary V. Woods
/s/ RICHARD L. LOVE * President, Chief Executive April 20, 2000
- ------------------------------------
Richard L. Love Officer, and a Director
(Principal Financial
Officer)
/s/ GREGORY L. WEAVER Vice President and Chief April 20, 2000
- ------------------------------------
Gregory L. Weaver Financial Officer
(Principal Financial and
Accounting Officer)
/s/ DANIEL D. VON HOFF, M.D. * Director April 20, 2000
- ------------------------------------
Daniel D. Von Hoff, M.D.
/s/ JOHN L. CASSIS * Director April 20, 2000
- ------------------------------------
John L. Cassis
</TABLE>
-2-
<PAGE> 4
<TABLE>
<S> <C> <C>
/s/ A. DANA CALLOW, JR. * Director April 20, 2000
- ------------------------------------
A. Dana Callow, Jr.
/s/ RUSKIN C. NORMAN, M.D. * Director April 20, 2000
- ------------------------------------
Ruskin C. Norman, M.D.
/s/ JASON S. FISHERMAN, M.D. * Director April 20, 2000
- ------------------------------------
Jason S. Fisherman, M.D.
/s/ JOSEPH S. BAILES, M.D. * Director April 20, 2000
- ------------------------------------
Joseph S. Bailes, M.D.
/s/ GLENN C. RICE, PH.D. * Director April 20, 2000
- ------------------------------------
Glenn C. Rice, Ph.D.
</TABLE>
* By: /s/ MICHAEL T. DWYER
----------------------------
Michael T. Dwyer,
Attorney-in-Fact
-3-
